Creative Financial Designs’s Emergent Biosolutions EBS Stock Holding History

Creative Financial Designs’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,126	Closed	-$56K	–	1263
2021 Q3	$56K	Hold	1,126	–	–	0.01%	587
2021 Q2	$71K	Hold	1,126	–	–	0.01%	517
2021 Q1	$105K	Hold	1,126	–	–	0.02%	407
2020 Q4	$101K	Hold	1,126	–	–	0.02%	378
2020 Q3	$116K	Hold	1,126	–	–	0.03%	313
2020 Q2	$89K	Buy	+1,126	New	+$83.9K	0.03%	310

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Creative Financial Designs's EBS Position: Q4 2021 in Review

Creative Financial Designs sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 1,126 shares — an estimated $56K sold.

Creative Financial Designs first reported a position in EBS in Q2 2020 and held it in 6 quarters. The position peaked at $116K in Q3 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Creative Financial Designs reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Creative Financial Designs sold 1,126 Emergent Biosolutions shares in Q4 2021, an estimated $56K.
Creative Financial Designs first reported a position in Emergent Biosolutions in Q2 2020 and held it in 6 quarters.
Creative Financial Designs's Emergent Biosolutions position peaked at $116K in Q3 2020.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.